Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Find the Historical backdrop of the Modern Unrest: Changing Society and Innovation - 2Green Inflections: A Manual for Inside Plants
- 3Vote in favor of Your #1 4K television: Lucidity and Drenching Matter
- 4The most effective method to Pick a Campervan That Offers Something else for Less
- 5‘Slender Man’ attacker back in custody. What we know about Morgan Geyser's disappearance and what happens next.
- 15 Preposterous Cosplay Ensembles That Will Blow You Away
- Manual for Tracking down Spending plan Agreeable Travel Objections
- Doritos and Cheetos debut 'NKD' options, without artificial colors or flavors
- Dominating the Mastercard Endorsement Cycle: Six Fundamental Stages
- Extreme Manual for Purchasing Your Next Truck
- From Loner to Force to be reckoned with: Individual Accounts of Change
- Zelensky sees win for Ukraine as EU finally reaches funding deal
- Find the Specialty of Public Speaking: Drawing in and Convincing Crowds with Certainty
- Faulty glucose monitors linked to 7 deaths and more than 700 injuries, FDA warns
